RESUMO
Fluorescent probes have been used as effective methods for profiling proteins in biological systems because of their high selectivity, sensitivity, and temporal-spatial resolution. A specific fluorescent probe for understanding the function of the transient receptor potential ankyrin 1 (TRPA1) channel that is closely related with various diseases like persistent pain, respiratory, and chronic itch syndromes, however, is still lacking. Here, we report a "turn-on" fluorescent probe (A1CA) for visualizing TRPA1 channels in the plasma membrane of live cells based on a photochromic ligand derived from 4-(phenylazo)benzenamine. Evaluating the specificity and sensitivity of A1CA by electrophysiology and confocal imaging showed that the A1CA probe displays higher affinity and selectivity to TRPA1 channel versus all other ion channels including TRPV1, TRPV3, Nav1.4, Nav1.5, and hERG. Based on the supporting evidence, A1CA has great potential as a molecular imaging probe for high-throughput screening of novel TRPA1 agonists.
Assuntos
Compostos Azo/química , Membrana Celular/química , Cumarínicos/química , Corantes Fluorescentes/química , Canal de Cátion TRPA1/análise , Animais , Compostos Azo/síntese química , Células CHO , Cumarínicos/síntese química , Cricetulus , Eletrofisiologia/métodos , Corantes Fluorescentes/síntese química , Ligantes , Microscopia Confocal/métodos , Canal de Cátion TRPA1/agonistas , Canal de Cátion TRPA1/antagonistas & inibidoresRESUMO
Sensory neurons innervating the dental pulp have unique morphological and functional characteristics compared to neurons innervating other tissues. Stimulation of dental pulp afferents whatever the modality or intensity of the stimulus, even light mechanical stimulation that would not activate nociceptors in other tissues, produces an intense pain. These specific sensory characteristics could involve receptors of the Transient Receptor Potential channels (TRP) family. In this study, we compared the expression of the cold sensitive receptors TRPM8 and TRPA1 in trigeminal ganglion neurons innervating the dental pulp, the skin of the cheek or the buccal mucosa and we evaluated the involvement of these receptors in dental pulp sensitivity to cold. We showed a similar expression of TRPM8, TRPA1 and CGRP in sensory neurons innervating the dental pulp, the skin or the mucosa. Moreover, we demonstrated that noxious cold stimulation of the tooth induced an overexpression of cFos in the trigeminal nucleus that was not prevented by the genetic deletion of TRPM8 or the administration of the TRPA1 antagonist HC030031. These data suggest that the unique sensory characteristics of the dental pulp are independent to TRPM8 and TRPA1 receptors expression and functionality.
Assuntos
Polpa Dentária/inervação , Células Receptoras Sensoriais/metabolismo , Canal de Cátion TRPA1/metabolismo , Canais de Cátion TRPM/metabolismo , Sensação Térmica , Gânglio Trigeminal/citologia , Animais , Células Cultivadas , Temperatura Baixa , Feminino , Masculino , Camundongos Endogâmicos C57BL , Células Receptoras Sensoriais/citologia , Pele/inervação , Canal de Cátion TRPA1/análise , Canais de Cátion TRPM/análise , Gânglio Trigeminal/metabolismoRESUMO
Increasing evidence suggests that extracellular miRNAs may serve as biomarkers of diseases, but the physiological relevance of extracellular miRNA is unclear. We find that intradermal cheek injection of miR-711 induces TRPA1-depedent itch (scratching) without pain (wiping) in naive mice. Extracellular perfusion of miR-711 induces TRPA1 currents in both Trpa1-expressing heterologous cells and native sensory neurons through the core sequence GGGACCC. Computer simulations reveal that the core sequence binds several residues at the extracellular S5-S6 loop of TRPA1, which are critical for TRPA1 activation by miR-711 but not allyl isothiocyanate. Intradermal inoculation of human Myla cells induces lymphoma and chronic itch in immune-deficient mice, associated with increased serum levels of miR-711, secreted from cancer cells. Lymphoma-induced chronic itch is suppressed by miR-711 inhibitor and a blocking peptide that disrupts the miR-711/TRPA1 interaction. Our findings demonstrated an unconventional physiological role of extracellular naked miRNAs as itch mediators and ion channel modulators.
Assuntos
Líquido Extracelular/metabolismo , MicroRNAs/metabolismo , Prurido/metabolismo , Canal de Cátion TRPA1/metabolismo , Doença Aguda , Adolescente , Adulto , Idoso de 80 Anos ou mais , Animais , Células CHO , Células Cultivadas , Doença Crônica , Cricetinae , Cricetulus , Líquido Extracelular/química , Feminino , Células HEK293 , Humanos , Masculino , Camundongos , Camundongos da Linhagem 129 , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos NOD , Camundongos Knockout , Camundongos Transgênicos , MicroRNAs/análise , Pessoa de Meia-Idade , Ligação Proteica/fisiologia , Prurido/patologia , Canal de Cátion TRPA1/análiseRESUMO
PURPOSE: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). METHODS: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5'-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. RESULTS: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. CONCLUSIONS: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.
Assuntos
Proteínas Quinases Ativadas por AMP/efeitos dos fármacos , Curcumina/análogos & derivados , Curcumina/farmacologia , Neuropatias Diabéticas/tratamento farmacológico , Canal de Cátion TRPA1/efeitos dos fármacos , Proteínas Quinases Ativadas por AMP/análise , Animais , Apoptose/efeitos dos fármacos , Western Blotting , Cálcio/análise , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/metabolismo , Neuropatias Diabéticas/metabolismo , Masculino , Microscopia de Fluorescência , Reação em Cadeia da Polimerase em Tempo Real , Reprodutibilidade dos Testes , Estreptozocina , Canal de Cátion TRPA1/análise , Fatores de TempoRESUMO
Abstract Purpose: To investigate the specific molecular mechanisms and effects of curcumin derivative J147 on diabetic peripheral neuropathy (DPN). Methods: We constructed streptozotocin (STZ)-induced DPN rat models to detected mechanical withdrawal threshold (MWT) in vivo using Von Frey filaments. In vitro, we measured cell viability and apoptosis, adenosine 5'-monophosphate-activated protein kinase (AMPK) and transient receptor potential A1 (TRPA1) expression using MTT, flow cytometry, qRT-PCR and western blot. Then, TRPA1 expression level and calcium reaction level were assessed in agonist AICAR treated RSC96cells. Results: The results showed that J147reduced MWT in vivo, increased the mRNA and protein level of AMPK, reduced TRPA1 expression and calcium reaction level in AITCR treated RSC96 cells, and had no obvious effect on cell viability and apoptosis. Besides, AMPK negative regulated TRPA1 expression in RSC96 cells. Conclusions: J147 could ameliorate DPN via negative regulation AMPK on TRPA1 in vivo and in vitro. A curcumin derivative J147might be a new therapeutic potential for the treatment of DPN.
Assuntos
Animais , Masculino , Curcumina/análogos & derivados , Curcumina/farmacologia , Neuropatias Diabéticas/tratamento farmacológico , Proteínas Quinases Ativadas por AMP/efeitos dos fármacos , Canal de Cátion TRPA1/efeitos dos fármacos , Fatores de Tempo , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Western Blotting , Cálcio/análise , Reprodutibilidade dos Testes , Apoptose/efeitos dos fármacos , Estreptozocina , Diabetes Mellitus Experimental/complicações , Diabetes Mellitus Experimental/metabolismo , Neuropatias Diabéticas/metabolismo , Proteínas Quinases Ativadas por AMP/análise , Reação em Cadeia da Polimerase em Tempo Real , Canal de Cátion TRPA1/análise , Microscopia de FluorescênciaRESUMO
The Notch1 pathway plays important roles in modulating erythroid and megakaryocyte differentiation. To screen the Notch1-related genes that regulate differentiation fate of K562 and HEL cells, the expression of transient receptor potential ankyrin 1 (TRPA1) was induced by Notch1 receptor intracellular domain (N1IC), the activated form of Notch1 receptor. N1IC and v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets-1) bound to TRPA1 promoter region to regulate transcription in K562 cells. Transactivation of TRPA1 promoter by N1IC depended on the methylation status of TRPA1 promoter. N1IC and Ets-1 suppressed the DNA methyltransferase 3B (DNMT3B) level in K562 cells. Inhibition of TRPA1 expression after Notch1 knockdown could be attenuated by nanaomycin A, an inhibitor of DNMT3B, in K562 and HEL cells. Functionally, hemin-induced erythroid differentiation could be suppressed by TRPA1, and the reduction of erythroid differentiation of both cells by N1IC and Ets-1 occurred via TRPA1. However, PMA-induced megakaryocyte differentiation could be enhanced by TRPA1, and the surface markers of megakaryocytes could be elevated by nanaomycin A. Megakaryocyte differentiation could be reduced by Notch1 or Ets-1 knockdown and relieved by TRPA1 overexpression. The results suggest that Notch1 and TRPA1 might be critical modulators that control the fate of erythroid and megakaryocyte differentiation.